NKTR-255 in combination with durvalumab following chemoradiation was well-tolerated in patients with non–small cell lung ...

Third, chemotherapy given as part of concurrent chemoradiation may act systemically and potentially eradicate distant micrometastases.

Atezolizumab did not improve overall survival, progression-free survival, distant metastasis-free survival, or time to local failure.

Therapeutics and collaborators at The University of Texas MD Anderson Cancer Center presented late-breaking results from a Phase ...

Summary and Introduction Clinical Application—Disease Entities Theoretical Framework for Therapy−The 'Steel Paradigm' Conclusion References Theoretical Framework for Therapy−The 'Steel ...

Updated findings from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study (NCT04221945) show the survival advantages of ...

The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an ...

Researchers at UCL and its associated hospital, University College London Hospital, spent 10 years studying patients who were given a short course of chemotherapy before chemoradiation ...

Researchers in London completed a long-term follow up of patients given a short course of chemotherapy before chemoradiation - a combination of chemotherapy and radiotherapy. The findings ...

The Edinburgh-based ceramics expert, 38, reflected on her health and 'how she's feeling about things' in a candid new article ...

A new report from leading contract research organisation Novotech has shed light on the current state of play in the global ...

It integrates a short course of chemotherapy before the standard chemoradiation treatment, aiming to improve survival rates and reduce relapses. The phase-three clinical trial, led by researchers ...